Qinghao (Artemisia annia L.) is a traditional Chiness herb which has been used in China for treating malaria for more than 1500 years. In 1971Chiness scientists extracted a compound from qinghao named Qinghaosu (artemisinine) which is an antimalarial. The China Cooperative Research Group on Qinghaosu and its Derivatives as Antimalarials was subsequently established to conduct […]
Professor Drew Weissman received his M.D. and Ph.D. from Boston University, USA before attended the training program with Dr. Anthony Fauci, who received the Prince Mahidol Award in the field of medicine in 2013, at the National Institutes of Health, Maryland, USA. Assoc. Prof. Karikó and Prof. Weissman have been working side by side in […]
Professor Pieter Cullis received his Ph.D. from the University of British Columbia and continued his research career there in lipid biochemistry. Prof. Cullis is a pioneer in lipid nanoparticles, which have been used for various applications in medicine such as delivering anticancer drugs to cancer tissues without causing too much toxicity in normal tissues. The […]
Professor Katalin Karikó received her Ph.D. from University of Szeged, Hungary. Prof. Karikó and Prof. Weissman have been working side by side in developing mRNA technology and its applications in medicine. In 2006, they discovered that modification of nucleosides in mRNA could reduce cellular reactions toward foreign RNA. This was an important step in the […]
Professor Dr. Valentin Fuster, M.D., Ph.D. Director, Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, New York , USA General Director of the National Center for Cardiovascular Research (CNIC), Madrid, Spain Editor-in-Chief of the Journal of the American College of Cardiology The United States of America Professor Dr. Valentin Fuster received […]
Bernard Pécoul, M.D., MPH. Founder and Executive Director, Drugs for Neglected Diseases initiative, (DNDi) The French Republic Dr.Bernard Pécoul received his Doctor of Medicine from the University of Clermont-Ferrand, France, and his Master of Public Health from Tulane University in the United States. Prior to engagement with the Drugs for Neglected Diseases initiative (DNDi), […]
Professor Dr. Mary-Claire King, Ph.D. Professor of Medical Genetics Department of Medicine, School of Medicine, University of Washington USA Professor Dr.Mary-Claire King, Ph.D. discovered a gene causing breast cancer, the most common cancer among women. Each year, there are over 2 million new cases of breast cancer resulting in 200,000 deaths. In 1991, Prof. King […]
Professor Dr. Ralf F.W. Bartenschlager Head of the Department for Infectious Diseases, Molecular Virology University of Heidelberg Head of the Division of Virus-Associated Carcinogenesis, German Cancer Research Center, Germany Professor Dr.Ralf F.W. Bartenschlager received his Ph.D. in Molecular Biology from the University of Heidelberg in 1990. He was appointed as Professor of Molecular Virology at […]
Professor David Mabey Professor of Communicable Diseases, Clinical Research Department, London School of Hygiene & Tropical Medicine United Kingdom Professor David Mabey received his Bachelor and Doctorate of Medicine degrees from Oxford University, United Kingdom. In 1994, he was appointed Professor of Communicable Diseases at the London School of Hygiene & Tropical Medicine. He […]
Professor Brian J. Druker, M.D. Professor of Medicine Director of Knight Cancer Institute, Oregon Health & Science University USA Professor Brian J. Druker, M.D. made a significant research discovery in the field of targeted cancer therapy. He developed a prototype drug called “Imatinib” for treatment of chronic myeloid leukemia (CML). Imatinib inhibits BCR-ABL, a specific […]
